Literature DB >> 17963462

Drug removal by plasmapheresis: an evidence-based review.

Rami B Ibrahim1, Chin Liu, Simon M Cronin, Bridgette C Murphy, Raymond Cha, Paul Swerdlow, David J Edwards.   

Abstract

Contrary to the literature about drug removal during hemodialysis, data regarding drug removal during plasmapheresis are sparse. Over the last 40 years, approximately 70 publications-mostly case reports of overdoses-have described the effects of plasmapheresis on pharmaceutical agents. Important issues are drug extraction during plasma exchange with chemotherapy, as well as drug classes such as antiinfectives, anticoagulants, antiepileptics, cardiovascular agents, and immunosuppressants. Other considerations are the merits and pitfalls of the different methods used in published reports and recommendations for future pharmacokinetic studies in this field.

Mesh:

Substances:

Year:  2007        PMID: 17963462     DOI: 10.1592/phco.27.11.1529

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  15 in total

Review 1.  Therapeutic plasma exchange for the treatment of pediatric renal diseases in 2013.

Authors:  Caitlin E Carter; Nadine M Benador
Journal:  Pediatr Nephrol       Date:  2013-06-29       Impact factor: 3.714

Review 2.  Designing drug regimens for special intensive care unit populations.

Authors:  Brian L Erstad
Journal:  World J Crit Care Med       Date:  2015-05-04

3.  Therapeutic Plasma Exchange for Refractory Hemolysis After Brown Recluse Spider (Loxosceles reclusa) Envenomation.

Authors:  Manjusha Abraham; Lowell Tilzer; K Sarah Hoehn; Stephen L Thornton
Journal:  J Med Toxicol       Date:  2015-09

4.  Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody-mediated disease.

Authors:  Florent Puisset; Mélanie White-Koning; Nassim Kamar; Antoine Huart; Frédérique Haberer; Hélène Blasco; Chantal Le Guellec; Thierry Lafont; Anaïs Grand; Lionel Rostaing; Etienne Chatelut; Jacques Pourrat
Journal:  Br J Clin Pharmacol       Date:  2013-11       Impact factor: 4.335

Review 5.  Extracorporeal Removal of Poisons and Toxins.

Authors:  Joshua David King; Moritz H Kern; Bernard G Jaar
Journal:  Clin J Am Soc Nephrol       Date:  2019-08-22       Impact factor: 8.237

6.  No alteration of voriconazole concentration by plasmapheresis in a critically ill patient.

Authors:  Manuela Vay; Kathrin I Foerster; Mazyar Mahmoudi; Jessica Seeßle; Gerd Mikus
Journal:  Eur J Clin Pharmacol       Date:  2018-10-22       Impact factor: 2.953

Review 7.  Drug Dosing in Patients Undergoing Therapeutic Plasma Exchange.

Authors:  Sherif Hanafy Mahmoud; Jessica Buhler; Eric Chu; Suzie A Chen; Theresa Human
Journal:  Neurocrit Care       Date:  2021-02       Impact factor: 3.210

Review 8.  Paraneoplastic syndromes: an approach to diagnosis and treatment.

Authors:  Lorraine C Pelosof; David E Gerber
Journal:  Mayo Clin Proc       Date:  2010-09       Impact factor: 7.616

9.  Progressive multifocal leukoencephalopathy during ixazomib-based chemotherapy.

Authors:  C P Sawicki; S A Climans; C C Hsia; J A Fraser
Journal:  Curr Oncol       Date:  2018-02-28       Impact factor: 3.677

10.  Measuring the Impact of Targeting FcRn-Mediated IgG Recycling on Donor-Specific Alloantibodies in a Sensitized NHP Model.

Authors:  Miriam Manook; Walter J Flores; Robin Schmitz; Zachary Fitch; Janghoon Yoon; Yeeun Bae; Brian Shaw; Allan Kirk; Melissa Harnois; Sallie Permar; Alton B Farris; Diogo M Magnani; Jean Kwun; Stuart Knechtle
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.